1 Min Read
April 9 (Reuters) - Verastem Inc:
* FDA ACCEPTS NEW DRUG APPLICATION FOR DUVELISIB AND GRANTS PRIORITY REVIEW
* FDA TARGET ACTION DATE IS OCTOBER 5, 2018 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.